Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hesperidin for treatment of diabetes
IRCT201407242602N12Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hesperidin in diabetes mellitus (DM), sponsored by Iran University of Medical Sciences. Started Sep 2014; status: completed.
02
Drugs
hesperidin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on IRCT201407242602N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201407242602N12.